Vasco Gama Ribeiro

Suggest Changes
Learn More
BACKGROUND Proton pump inhibitors (PPIs) are usually prescribed to patients undergoing dual antiplatelet therapy to decrease the risk of gastrointestinal bleeding. Recent studies have raised concerns(More)